|
---|
| 血管生成素(英语:Angiopoietin receptor) | - 受體激動劑:血管生成素1(英语:Angiopoietin 1)
- 血管生成素4(英语:Angiopoietin 4)
- 受體拮抗劑:血管生成素2(英语:Angiopoietin 2)
- 血管生成素3
- 激酶抑制劑:Altiratinib
- CE-245677
- Rebastinib(英语:Rebastinib)
- 抗體: Evinacumab(英语:Evinacumab) (against angiopoietin 3)
- 奈伐库单抗 (against angiopoietin 2)
|
---|
| CNTF(英语:Ciliary neurotrophic factor receptor) | - 受體激動劑:Axokine(英语:Axokine)
- CNTF(英语:Ciliary neurotrophic factor receptor)
- Dapiclermin
|
---|
| EGF(ErbB) | 表皮生长因子受体 (EGF(ErbB1/HER1)) | - 受體激動劑:Amphiregulin(英语:Amphiregulin)
- Betacellulin(英语:Betacellulin)
- EGF(尿抑腸素)
- Epigen(英语:Epigen)
- Epiregulin(英语:Epiregulin)
- 人類肝素結合表皮生長因子(英语:Heparin-binding EGF-like growth factor)(HB-EGF)
- Murodermin(英语:Murodermin)
- Nepidermin(英语:Nepidermin)
- 转化生长因子-α(TGFα)
- 激酶抑制劑:阿法替尼
- AG-490
- Agerafenib
- Brigatinib(英语:Brigatinib)
- Canertinib(英语:Canertinib)
- 达可替尼
- 厄洛替尼
- 吉非替尼
- Grandinin(英语:Grandinin)
- Icotinib(英语:Icotinib)
- 拉帕替尼
- Neratinib(英语:Neratinib)
- 奥希替尼
- Vandetanib(英语:Vandetanib)
- WHI-P 154
- 抗體: 西妥昔單抗
- Depatuxizumab
- Depatuxizumab mafodotin(英语:Depatuxizumab mafodotin)
- 伏妥昔单抗
- 英加妥珠单抗
- Matuzumab(英语:Matuzumab)
- 耐昔妥珠单抗
- Nimotuzumab(英语:Nimotuzumab)
- Panitumumab(英语:Panitumumab)
- Zalutumumab(英语:Zalutumumab)
|
---|
| ErbB2/HER2 | - 抗體: 厄妥索单抗
- 帕妥珠单抗
- 曲妥珠单抗
- Trastuzumab duocarmazine
- Trastuzumab emtansine(英语:Trastuzumab emtansine)
- 激酶抑制劑:阿法替尼
- AG-490
- 拉帕替尼
- Mubritinib(英语:Mubritinib)
- Neratinib(英语:Neratinib)
|
---|
| ErbB3/HER3(英语:HER3) | - 受體激動劑:Neuregulins (heregulins)(英语:Neuregulin) (1(英语:Neuregulin-1), 2(英语:NRG2), 6 (neuroglycan C)(英语:CSPG5))
|
---|
| ErbB4/HER4(英语:HER4) | - 受體激動劑:Betacellulin(英语:Betacellulin)
- Epigen(英语:Epigen)
- Heparin-binding EGF-like growth factor (HB-EGF)(英语:Heparin-binding EGF-like growth factor)
- Neuregulins (heregulins)(英语:Neuregulin) (1(英语:Neuregulin-1), 2(英语:NRG2), 3(英语:NRG3), 4(英语:NRG4), 5 (tomoregulin, TMEFF))
|
---|
|
---|
| FGF | FGFR1(英语:Fibroblast growth factor receptor 1) | - 受體激動劑:Ersofermin
- FGF (1(英语:FGF1), 2 (bFGF)(英语:FGF2), 3(英语:FGF3), 4(英语:FGF4), 5(英语:FGF5), 6(英语:FGF6), 8(英语:FGF8), 10 (KGF2)(英语:FGF10), 20(英语:FGF20))
- Repifermin
- Trafermin(英语:Trafermin)
- Velafermin
|
---|
| FGFR2(英语:Fibroblast growth factor receptor 2) | - 受體激動劑:Ersofermin
- FGF (1(英语:FGF1), 2 (bFGF)(英语:FGF2), 3(英语:FGF3), 4(英语:FGF4), 5(英语:FGF5), 6(英语:FGF6), 7(英语:FGF7) (KGF(英语:keratinocyte growth factor)), 8(英语:FGF8), 9(英语:FGF9), 10 (KGF2)(英语:FGF10), 17(英语:FGF17), 18(英语:FGF18), 22(英语:FGF22))
- Palifermin(英语:Palifermin)
- Repifermin
- Sprifermin(英语:Sprifermin)
- Trafermin(英语:Trafermin)
- 抗體: Aprutumab
- Aprutumab ixadotin
|
---|
| FGFR3(英语:Fibroblast growth factor receptor 3) | - 受體激動劑:Ersofermin
- FGF (1(英语:FGF1), 2 (bFGF)(英语:FGF2), 4(英语:FGF4), 8(英语:FGF8), 9(英语:FGF9), 18(英语:FGF18), 23(英语:FGF23))
- Sprifermin(英语:Sprifermin)
- Trafermin(英语:Trafermin)
- 抗體: Burosumab(英语:Burosumab) (against FGF23)
|
---|
| FGFR4(英语:Fibroblast growth factor receptor 4) | - 受體激動劑:Ersofermin
- FGF (1(英语:FGF1), 2 (bFGF)(英语:FGF2), 4(英语:FGF4), 6(英语:FGF6), 8(英语:FGF8), 9(英语:FGF9), 19(英语:FGF19))
- Trafermin(英语:Trafermin)
|
---|
| Unsorted | - 受體激動劑:FGF15/19(英语:FGF15/19)
|
---|
|
---|
| HGF (c-Met)(英语:Hepatocyte growth factor receptor) | - 受體激動劑:Hepatocyte growth factor(英语:Hepatocyte growth factor)
- Potentiators: Dihexa (PNB-0408)(英语:Dihexa)
- 激酶抑制劑:Altiratinib
- AM7
- AMG-458
- Amuvatinib
- BMS-777607
- Cabozantinib(英语:Cabozantinib)
- Crizotinib(英语:Crizotinib)
- Foretinib(英语:Foretinib)
- Golvatinib
- INCB28060
- JNJ-38877605
- K252a
- MK-2461
- PF-04217903
- PF-2341066
- PHA-665752
- SU-11274
- Tivantinib(英语:Tivantinib)
- Volitinib(英语:Volitinib)
|
---|
| IGF(英语:Somatomedin receptor) | IGF-1 | - 受體激動劑:des(1-3)IGF-1(英语:des(1-3)IGF-1)
- 胰岛素样生长因子1(生長調節素C)
- IGF-1 LR3(英语:IGF-1 LR3)
- Insulin-like growth factor-2 (somatomedin A)(英语:Insulin-like growth factor 2)
- Insulin
- Mecasermin(英语:Mecasermin)
- Mecasermin rinfabate(英语:Mecasermin rinfabate)
- 激酶抑制劑:BMS-754807
- Linsitinib(英语:Linsitinib)
- NVP-ADW742
- NVP-AEW541
- OSl-906
- 抗體: AVE-1642
- Cixutumumab(英语:Cixutumumab)
- Dalotuzumab(英语:Dalotuzumab)
- 芬妥木单抗
- 加尼妥单抗
- 罗妥木单抗
- R1507
- Teprotumumab(英语:Teprotumumab)
- Xentuzumab (against IGF-1 and IGF-2)
|
---|
| IGF-2(英语:Insulin-like growth factor 2 receptor) | - 受體激動劑:Insulin-like growth factor-2 (somatomedin A)(英语:Insulin-like growth factor 2)
- 抗體: 度司妥单抗
- Xentuzumab (against IGF-1 and IGF-2)
|
---|
| 其他 | - Binding proteins: IGFBP(英语:Insulin-like growth factor-binding protein) (1(英语:IGFBP1), 2(英语:IGFBP2), 3(英语:IGFBP3), 4(英语:IGFBP4), 5(英语:IGFBP5), 6(英语:IGFBP6), 7(英语:IGFBP7))
- Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
- 曲非奈肽(英语:Trofinetide)
|
---|
|
---|
| LNGF (p75NTR)(英语:Low-affinity nerve growth factor receptor) | - 受體激動劑:BDNF
- BNN-20(英语:BNN-20)
- BNN-27(英语:BNN-27)
- Cenegermin(英语:Cenegermin)
- DHEA
- DHEA-S(英语:Dehydroepiandrosterone sulfate)
- NGF(英语:Nerve growth factor)
- NT-3(英语:Neurotrophin-3)
- NT-4(英语:Neurotrophin-4)
- 受體拮抗劑:ALE-0540
- 地塞米松
- EVT-901 (SAR-127963)
- 睾酮
- 抗體: 抗NGF: ABT-110 (PG110)
- ASP-6294
- 法司努单抗
- Frunevetmab(英语:Frunevetmab)
- Fulranumab(英语:Fulranumab)
- MEDI-578
- Ranevetmab(英语:Ranevetmab)
- 他尼珠单抗
- Aptamers: Against NGF: RBM-004
|
---|
| PDGF | - 受體激動劑:Becaplermin(英语:Becaplermin)
- PDGF(A(英语:PDGFA), B(英语:PDGFB), C(英语:PDGFC), D(英语:PDGFD))
- 激酶抑制劑:Agerafenib
- Axitinib(英语:Axitinib)
- Crenolanib(英语:Crenolanib)
- 伊马替尼
- Lenvatinib(英语:Lenvatinib)
- 马赛替尼
- Motesanib(英语:Motesanib)
- 尼達尼布
- Pazopanib(英语:Pazopanib)
- Radotinib(英语:Radotinib)
- Quizartinib(英语:Quizartinib)
- 舒尼替尼
- 索拉非尼
- Toceranib(英语:Toceranib)
- 抗體: Olaratumab(英语:Olaratumab)
- Ramucirumab(英语:Ramucirumab)
- Tovetumab(英语:Tovetumab)
|
---|
| RET (GFL)(英语:RET proto-oncogene) | GFRα1(英语:GFRα1) | - 受體激動劑:Glial cell line-derived neurotrophic factor (GDNF)(英语:Glial cell line-derived neurotrophic factor)
- Liatermin
- 激酶抑制劑:Vandetanib(英语:Vandetanib)
|
---|
| GFRα2(英语:GFRα2) | - 受體激動劑:Neurturin (NRTN)(英语:Neurturin)
- 激酶抑制劑:Vandetanib(英语:Vandetanib)
|
---|
| GFRα3(英语:GFRα3) | - 受體激動劑:Artemin (ARTN)(英语:Artemin)
- 激酶抑制劑:Vandetanib(英语:Vandetanib)
|
---|
| GFRα4(英语:GFRα4) | - 受體激動劑:Persephin (PSPN)(英语:Persephin)
- 激酶抑制劑:Vandetanib(英语:Vandetanib)
|
---|
| Unsorted | |
---|
|
---|
| SCF (c-Kit)(英语:CD117) | - 受體激動劑:Ancestim(英语:Ancestim)
- Stem cell factor(英语:Stem cell factor)
- 激酶抑制劑:Agerafenib
- Axitinib(英语:Axitinib)
- 达沙替尼
- 伊马替尼
- 马赛替尼
- 尼罗替尼
- Pazopanib(英语:Pazopanib)
- Quizartinib(英语:Quizartinib)
- 索拉非尼
- 舒尼替尼
- Toceranib(英语:Toceranib)
|
---|
| TGFβ(英语:Transforming growth factor beta receptor) | - See here(英语:Template:TGFβ_receptor_superfamily_modulators) instead.
|
---|
| Trk | TrkA(英语:TrkA receptor) | - 受體激動劑:Amitriptyline
- BNN-20(英语:BNN-20)
- BNN-27(英语:BNN-27)
- Cenegermin(英语:Cenegermin)
- DHEA
- DHEA-S(英语:Dehydroepiandrosterone sulfate)
- Gambogic amide
- NGF(英语:Nerve growth factor)
- Tavilermide(英语:Tavilermide)
- 受體拮抗劑:ALE-0540
- 地塞米松
- FX007(英语:FX007)
- 睾酮
- Negative allosteric modulators: VM-902A
- 激酶抑制劑:Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib(英语:Entrectinib)
- GZ-389988
- K252a
- Larotrectinib(英语:Larotrectinib)
- Lestaurtinib(英语:Lestaurtinib)
- Milciclib
- ONO-4474
- ONO-5390556
- PLX-7486
- Rebastinib(英语:Rebastinib)
- SNA-120 (pegylated K252a))
- 抗體: Against TrkA: GBR-900; Against NGF: ABT-110 (PG110)
- ASP-6294
- 法司努单抗
- Frunevetmab(英语:Frunevetmab)
- Fulranumab(英语:Fulranumab)
- MEDI-578
- Ranevetmab(英语:Ranevetmab)
- Tanezumab(英语:Tanezumab)
- Aptamers: Against NGF: RBM-004
|
---|
| TrkB(英语:TrkB receptor) | - 受體激動劑:3,7-DHF
- 3,7,8,2'-THF
- 4'-DMA-7,8-DHF(英语:4'-Dimethylamino-7,8-dihydroxyflavone)
- 7,3'-DHF
- 7,8-DHF(英语:7,8-Dihydroxyflavone)
- 7,8,2'-THF
- 7,8,3'-THF(英语:7,8,3'-Trihydroxyflavone)
- 阿米替林
- BDNF
- BNN-20(英语:BNN-20)
- Deoxygedunin(英语:Deoxygedunin)
- Deprenyl(英语:Deprenyl)
- Diosmetin(英语:Diosmetin)
- DMAQ-B1
- HIOC(英语:HIOC)
- LM22A-4(英语:LM22A-4)
- N-乙酰血清素
- NT-3(英语:Neurotrophin-3)
- NT-4(英语:Neurotrophin-4)
- Norwogonin (5,7,8-THF)(英语:Norwogonin)
- R7(英语:R7 (drug))
- TDP6
- 受體拮抗劑:ANA-12(英语:ANA-12)
- Cyclotraxin B(英语:Cyclotraxin B)
- Gossypetin (3,5,7,8,3',4'-HHF)(英语:Gossypetin)
- 激酶抑制劑:Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib(英语:Entrectinib)
- GZ-389988
- K252a
- Larotrectinib(英语:Larotrectinib)
- Lestaurtinib(英语:Lestaurtinib)
- ONO-4474
- ONO-5390556
- PLX-7486
|
---|
| TrkC(英语:TrkC receptor) | - 受體激動劑:BNN-20(英语:BNN-20)
- DHEA
- NT-3(英语:Neurotrophin-3)
- 激酶抑制劑:Altiratinib
- AZD-6918
- CE-245677
- CH-7057288
- DS-6051
- Entrectinib(英语:Entrectinib)
- GZ-389988
- K252a
- Larotrectinib(英语:Larotrectinib)
- Lestaurtinib(英语:Lestaurtinib)
- ONO-4474
- ONO-5390556
- PLX-7486
|
---|
|
---|
| VEGF(英语:Vascular endothelial growth factor receptor) | - 受體激動劑:Placental growth factor (PGF)(英语:Placental growth factor)
- Telbermin
- VEGF (A(英语:Vascular endothelial growth factor A), B(英语:Vascular endothelial growth factor B), C(英语:Vascular endothelial growth factor C), D (FIGF)(英语:Vascular endothelial growth factor D))
- Allosteric modulators: Cyclotraxin B(英语:Cyclotraxin B)
- 激酶抑制劑:Agerafenib
- Altiratinib
- Axitinib(英语:Axitinib)
- Cabozantinib(英语:Cabozantinib)
- Cediranib(英语:Cediranib)
- 拉帕替尼
- Lenvatinib(英语:Lenvatinib)
- Motesanib(英语:Motesanib)
- 尼達尼布
- Pazopanib(英语:Pazopanib)
- Pegaptanib(英语:Pegaptanib)
- Rebastinib(英语:Rebastinib)
- Regorafenib(英语:Regorafenib)
- Semaxanib(英语:Semaxanib)
- 索拉非尼
- 舒尼替尼
- Toceranib(英语:Toceranib)
- Tivozanib(英语:Tivozanib)
- Vandetanib(英语:Vandetanib)
- WHI-P 154
- 抗體: Alacizumab pegol(英语:Alacizumab pegol)
- 安维汀
- 艾芦库单抗
- Ramucirumab(英语:Ramucirumab)
- 兰尼单抗
- 誘餌受體:Aflibercept(英语:Aflibercept)
|
---|
| 其他 | - Additional growth factors: Adrenomedullin(英语:Adrenomedullin)
- Colony-stimulating factor(英语:Colony-stimulating factor)s (see here instead)
- Connective tissue growth factor (CTGF)(英语:Connective tissue growth factor)
- Ephrin(英语:Ephrin)s (A1(英语:EFNA1), A2(英语:EFNA2), A3(英语:EFNA3), A4(英语:EFNA4), A5(英语:EFNA5), B1(英语:EFNB1), B2(英语:EFNB2), B3(英语:EFNB3))
- 紅血球生成素 (see here instead)
- 葡萄糖-6-磷酸異構酶(GPI; PGI, PHI, AMF)
- Glia maturation factor (GMF)(英语:Glia maturation factor)
- Hepatoma-derived growth factor (HDGF)(英语:Hepatoma-derived growth factor)
- 白细胞介素/T-cell growth factor(英语:T-cell growth factor)s (see here instead)
- 白血病抑制因子(LIF)
- Macrophage-stimulating protein (MSP; HLP, HGFLP)(英语:Macrophage-stimulating protein)
- Midkine (NEGF2)(英语:Midkine)
- Migration-stimulating factor (MSF; PRG4)(英语:Migration-stimulating factor)
- Oncomodulin(英语:Oncomodulin)
- Pituitary adenylate cyclase-activating peptide (PACAP)(英语:Pituitary adenylate cyclase-activating peptide)
- Pleiotrophin(英语:Pleiotrophin)
- Renalase(英语:Renalase)
- 促血小板生成素 (see here instead)
- Wnt信号通路
- Additional growth factor receptor modulators: Cerebrolysin(英语:Cerebrolysin) (neurotrophin mixture)
|
---|
| - 參見
- Receptor/signaling modulators
- Signaling peptide/protein receptor modulators
- Cytokine receptor modulators
|
|